Search

everythinglearnresearchcommunity

for

Search:↓

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Certain drugs can change hair color, either lightening or darkening it.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Targeting regulatory T cells may help treat age-related diseases.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Benign follicular mucinosis involves immune cells attacking hair follicles.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Phospholipase A2 enzymes play key roles in skin health and disease.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

Extracellular vesicles can help treat skin issues like wounds, hair loss, aging, and inflammation.